Edition:
United States

Aeglea Bio Therapeutics Inc (AGLE.OQ)

AGLE.OQ on NASDAQ Stock Exchange Global Market

6.32USD
3:59pm EST
Change (% chg)

$0.16 (+2.60%)
Prev Close
$6.16
Open
$6.05
Day's High
$6.37
Day's Low
$6.04
Volume
20,403
Avg. Vol
14,884
52-wk High
$8.14
52-wk Low
$2.81

Revenue & Earnings Per Share

    Revenue* Earnings Per Share**
FY 2017 Sep '17 1.26 -0.480
Jun '17 1.48 -0.470
Mar '17 0.98 -0.467
FY 2016 Dec '16 1.25 -0.410
Sep '16 1.15 -0.468
Jun '16 1.37 -0.461
Mar '16 0.86 -0.398
 
*Note: Units in Millions ofU.S. Dollars
**Note: Units in U.S. Dollars

Consensus Estimates Analysis

  # of Estimates Mean High Low 1 Year Ago
SALES (in millions)
Quarter Ending Mar-18 3 1.13 2.00 0.00 --
Quarter Ending Jun-18 3 1.14 2.03 0.00 --
Year Ending Dec-18 5 2.37 5.00 0.00 0.50
Earnings (per share)
Quarter Ending Mar-18 3 -0.49 -0.43 -0.61 --
Quarter Ending Jun-18 3 -0.45 -0.44 -0.47 --
Year Ending Dec-18 5 -2.10 -1.98 -2.33 -2.81
Sales and Profit Figures in US Dollar (USD);

Valuation Ratios

  Company industry sector
P/E Ratio (TTM) -- 180.40 35.76
P/E High - Last 5 Yrs. -- 281.08 46.66
P/E Low - Last 5 Yrs. -- 92.01 24.18
Beta -- 0.81 0.81
Price to Sales (TTM) 20.37 141.46 8.59
Price to Book (MRQ) 1.80 19.13 5.23
Price to Tangible Book (MRQ) 1.82 25.71 6.37
Price to Cash Flow (TTM) -- 120.28 26.13
% Owned Institutions 63.96 12.01 2.31

Dividends

  Company industry sector
Dividend Yield -- 0.29 1.50
Dividend Yield - 5 Year Avg -- 0.20 2.01
Dividend 5 Year Growth Rate -- 1.84 5.25
Payout Ratio(TTM) -- 8.47 44.77

Growth Rates

  Company industry sector
Sales (MRQ) vs Qtr. 1 Yr. Ago 9.75 43.81 9.62
Sales (TTM) vs TTM 1 Yr. Ago 0.06 45.25 7.31
Sales - 5 Yr. Growth Rate -- 32.48 10.20
EPS (MRQ) vs Qtr. 1 Yr. Ago -2.51 6.77 18.60
EPS (TTM) vs TTM 1 Yr. Ago -9.03 -- --
EPS - 5 Yr. Growth Rate -- 45.74 11.47
Capital Spending - 5 Yr. Growth Rate -- 41.90 14.75

Financial Strength

  Company industry sector
Quick Ratio (MRQ) -- 1.77 2.43
Current Ratio (MRQ) 12.20 6.14 3.39
LT Debt to Equity (MRQ) 0.00 16.68 11.95
Total Debt to Equity (MRQ) 0.00 18.86 15.32
Interest Coverage (TTM) -- -165.00 38.67

Profitability Ratios

  Company industry sector
Gross Margin (TTM) -- 50.66 54.89
Gross Margin - 5 Yr. Avg. -- 55.48 52.59
EBITD Margin (TTM) -530.75 -- --
EBITD - 5 Yr. Avg -- -563.40 10.03
Operating Margin (TTM) -535.16 -589.85 2.96
Operating Margin - 5 Yr. Avg. -- -584.40 5.27
Pre-Tax Margin (TTM) -527.99 -559.39 3.78
Pre-Tax Margin - 5 Yr. Avg. -- -592.51 5.53
Net Profit Margin (TTM) -527.99 -554.46 0.26
Net Profit Margin - 5 Yr. Avg. -- -596.29 1.79
Effective Tax Rate (TTM) -- -0.06 22.06
Effective Tax Rate - 5 Yr. Avg. -- 17.84 24.20

Efficiency

  Company industry sector
Revenue/Employee (TTM) 165,633 23,379,765 824,372,705
Net Income/Employee (TTM) -874,533 -413,169 96,444,553
Receivable Turnover (TTM) 2.47 14.82 5.41
Inventory Turnover (TTM) -- 2.46 3.49
Asset Turnover (TTM) 0.07 0.39 0.90

Management Effectiveness

  Company industry sector
Return on Assets (TTM) -39.58 -0.92 10.73
Return on Assets - 5 Yr. Avg. -- -0.52 12.02
Return on Investment (TTM) -42.37 -0.52 13.59
Return on Investment - 5 Yr. Avg. -- 2.04 15.73
Return on Equity (TTM) -42.42 -3.30 15.20
Return on Equity - 5 Yr. Avg. -- -2.17 16.95
  1 Year 3 Year 5 Year
Sales % -23.94 -- --
EPS (TTM) % -119.80 -- --
Dividend % -- -- --
Note: Units in Millions of US Dollars

Performance for Aeglea Bio Therapeutics Inc

Note:: Rank is a percentile that ranges from 0 to 99, with 99 = best.

Institutional Holders

% Shares Owned: 63.96%
# of Holders: 41
Total Shares Held: 10,645,790
3 Mo. Net Change: 153,052
# New Positions: 6
# Closed Positions: 5
# Increased Positions: 19
# Reduced Positions: 9
# Net Buyers: 10
NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.